Search This Blog

Thursday, February 5, 2026

Bristol Myers Rises Inside A Buy Zone On Street-Beating 2026 Outlook

 Bristol Myers Squibb (BMY) stock rose moderately on Thursday after the drugmaker reported adjusted earnings of $1.26 per share on $12.5 billion in fourth-quarter sales.

On average, analysts polled by FactSet expected Bristol Myers to earn $1.23 per share and report $12.28 billion in sales.

During the year-ago period, the company earned $1.67 a share on $12.34 billion in sales.

For the year, Bristol Myers Squibb guided to adjusted profit of $6.05 to $6.35 a share and $46 billion to $47.5 billion in sales. Analysts called for $6.02 earnings per share and $44.18 billion in sales.

In premarket trades on today's stock market, Bristol Myers Squibb stock edged up 1% to 58.20. Shares broke out on Wednesday, topping a buy point at 57.04 out of a lengthy cup-with-handle base, according to MarketSurge. The buy zone runs up to 59.89.

https://www.investors.com/news/technology/bristol-myers-squibb-stock-bristol-myers-squibb-earnings-q4-2025/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.